Related Experiment Video
Updated: Aug 5, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Features of Obstructive Sleep Apnea in Children with and without Comorbidities
Eusebi Chiner1, Jose N Sancho-Chust1, Esther Pastor1
1Pulmonology Department, Multidisciplinary Sleep Clinic, San Juan de Alicante University Hospital, 03550 Alicante, Spain.
Insights
Children with obstructive sleep apnea (OSA) and comorbidities often have obesity and facial anomalies, requiring combined treatments like ventilation and surgery. Group A (adenotonsillar hypertrophy) showed better outcomes than Group B (comorbidities).
Area of Science:
- Pediatric Sleep Medicine
- Otolaryngology
- Genetics and Genomics
Background:
- Obstructive sleep apnea (OSA) in children presents diverse clinical and polysomnographic features.
- Distinguishing OSA in children with adenotonsillar hypertrophy versus those with comorbidities is crucial for tailored management.
Purpose of the Study:
- To compare clinical and polysomnographic characteristics of pediatric obstructive sleep apnea (OSA).
- To evaluate differences between children with OSA due to adenotonsillar hypertrophy (Group A) and those with comorbidities (Group B).
Main Methods:
- A five-year prospective study involving 168 children diagnosed with OSA.
- Nocturnal polysomnography was conducted before and after therapeutic interventions.
- Patients were categorized into Group A (adenotonsillar hypertrophy) and Group B (comorbidities).
Main Results:
- Group B patients were older, had higher BMIs and neck circumferences, and a greater prevalence of obesity compared to Group A.
- Facial anomalies, macroglossia, dolichocephaly, micrognathia, and prognathism were significantly more common in Group B.
- Adenotonsillectomy was performed more frequently in Group A, while Group B required more ventilation (CPAP/BiPAP) and maxillofacial surgery; both groups improved, but Group A showed better outcomes.
Conclusions:
- Pediatric OSA patients with comorbidities (Group B) exhibit higher rates of obesity and facial anomalies.
- These children often necessitate combination therapies, including positive airway pressure ventilation and surgical interventions.
- While treatment improves outcomes in both groups, children with isolated adenotonsillar hypertrophy (Group A) tend to achieve better results.
Background:
To compare the clinical and polysomnographic features of obstructive sleep apnea (OSA) in children with adenotonsillar hypertrophy (Group A) and comorbidities (Group B).
Methods:
A five-year prospective study using nocturnal polysomnography before and after treatment.
Results:
We included 168 patients: 121 in Group A and 47 in Group B, with differences in age (6.5 ± 3 vs. 8.6 ± 4 years; p < 0.001), body mass index (BMI) (18 ± 4 vs. 20 ± 7 kg/m2; p < 0.05), neck circumference (28 ± 4 vs. 30 ± 5 cm; p < 0.05), and obesity (17% vs. 30%; p < 0.05). Group B patients were more likely to have facial anomalies (p < 0.001), macroglossia (p < 0.01), dolichocephaly (p < 0.01), micrognathia (p < 0.001), and prognathism (p < 0.05). Adenotonsillectomy was performed in 103 Group A patients (85%) and 28 Group B patients (60%) (p < 0.001). In B, 13 children (28%) received treatment with continuous positive airway pressure (CPAP) and 2 (4%) with bilevel positive airway pressure (BiPAP), compared with 7 in Group A (6%) (p < 0.001). Maxillofacial surgery was more common in Group B (p < 0.01). Clinical and polysomnography parameters improved significantly in both groups after therapeutic intervention, though Group A showed better results.
Conclusions:
Obesity and facial anomalies are more frequent in childhood OSA patients with comorbidities, who often require combination therapy, such as ventilation and surgery.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Nightmares and Night Terrors
Nightmares...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

